RankAlpha logo
Back to Rankings

MCRB

Seres TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
MCRB vs peer average
56/100
MCRB vs. peer average (D vs. D)
Grade spread
C 1 · D 3 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

VERU is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $44.84M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerVERUVeru
MCRB
Seres Therapeutics
VERU
Veru
Grade
D
F
Momentum
50
14
Value
44
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs VERU

MCRB / VERU
Grade Position
In line
MCRB vs. peer average (D vs. D)
56/100
Momentum
50
MCRB
Value
44
MCRB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MCRB
1
VERU
Veru Inc Common
F
20/100
+1
2
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
F
20/100
+1
3
GRCE
Grace Therapeutics Inc Common
C
60/100
-1
4
HYPD
Hyperion DeFi Inc Common
D
40/100
Even
5
MDXH
MDxHealth SA Common
F
20/100
+1
VERU is the first peer returned for this comparison set.